Buscar resultados de ensayos clínicos
Primary Sclerosing Cholangitis - 31 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis Condición: Primary Sclerosing Cholangitis Fecha: 2016-06-13 Intervenciones:
|
Completed |
Nombre del estudio: Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC) Condición: Primary Sclerosing Cholangitis (PSC) Fecha: 2012-08-22 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) Condición: Primary Sclerosing Cholangitis (PSC) Fecha: 2014-06-26 Intervenciones:
|
Completed |
Nombre del estudio: Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis (PSC) Fecha: 2014-02-11 Intervenciones: Drug: LUM001 LUM001 oral dose |
Recruiting |
Nombre del estudio: Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures Condición: Primary Sclerosing Cholangitis Fecha: 2015-12-09 Intervenciones: Device: probe based confocal laser endomicroscopy real-time, microscopic imaging of tissue at the cellul |
NOT_YET_RECRUITING |
Nombre del estudio: CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) Condición: Fecha: 2024-05-19 Intervenciones: Oral QD |
RECRUITING |
Nombre del estudio: Detoxification of the Liver In PSC (Dolphin) Condición: Primary Sclerosing Cholangitis Fecha: 2024-05-19 Intervenciones: Groups 1, 2, 3, and 4 will all contain 7 subjects each, with each subject receiving active study drug and placebo in a randomized order; half will rec |
RECRUITING |
Nombre del estudio: Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach Condición: Primary Sclerosing Cholangitis Fecha: 2024-05-19 |
RECRUITING |
Nombre del estudio: Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study Condición: Primary Sclerosing Cholangitis Fecha: 2024-05-19 Intervenciones: Rosuvastatin 20 mg tablet once daily by mouth |
RECRUITING |
Nombre del estudio: A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. Condición: Primary Sclerosing Cholangitis Fecha: 2024-05-19 Intervenciones: Oral Tablet |